The Psychedelic Morning Brief
đź’— MDMA May Work Without the Mystical Experience
Synopsis: A new analysis of MDMA-assisted therapy for PTSD found that mystical experiences themselves did not significantly explain improvements in PTSD symptoms. Instead, the strongest link was positive emotional states: feelings of joy, peace & love.
My Take: This is important because we have a tendency to lump every Psychedelic into the same bucket. MDMA isn't Psilocybin, and it may not need ego dissolution, God or the cosmos to work. Feeling love, open & connected is enough.
🍄 Psilocybin Shows Promise for Lingering Lyme Disease Symptoms
Synopsis: In a small Johns Hopkins pilot study, 20 people with post-treatment Lyme disease received 2 supervised doses of Psilocybin. Participants reported substantial reductions in overall symptoms, depression, fatigue & pain that persisted for months.
My Take: Exactly the kind of Psychedelic research I want to see more of. Depression gets most of the attention, but the more interesting frontier may be conditions we don't currently treat very well.
🌿 What Brazil's Jurema Tradition Can Teach Psychedelic Medicine
Synopsis: NPR spoke with science journalist Marcelo Leite about jurema preta, a DMT-containing tree with centuries of ceremonial use among Indigenous & Afro-Brazilian communities in northeastern Brazil. Leite argues that Western psychedelic medicine risks focusing so heavily on the molecule that it underestimates the role of ritual, culture, community & setting.
My Take: There's a middle ground between pretending Indigenous traditions have nothing to teach us & romanticizing them as possessing some mystical truth Western science can't touch. Psychedelics have always been more than pharmacology…context matters, culture matters & the molecule matters.
